Equity in the Treatment of Penicillin Allergy
Promoting optimal allergy care and medical treatments for patients in every community
10% of people in the US are labelled with a penicillin allergy on their medical record, but more than 9 in 10 individuals carrying a penicillin allergy label are not truly allergic.
Penicillin allergy labels affect choices of antibiotics when individuals get sick, leading to widespread health consequences for patients and hospitals.
Removing inaccurate penicillin allergy labels (“de-labeling”) is a safe and recommended strategy to improve antibiotic prescribing.
However, access to de-labeling services is limited and available unevenly across communities.
Our study team aims to connect with patients, clinicians, and other health professionals in our local communities and investigate ways to improve the access to and perceptions of de-labeling penicillin allergies.
Do you have a penicillin allergy?
Do you see a primary care doctor at Mass General Hospital, Brigham and Women’s Hospital, or Tufts Medicine?
If you answered yes, we want to hear from you about your experience and views on your penicillin allergy. Contact the study team to find out more.
Participation involves attending either an in-depth interview or a focus group session about your penicillin allergy experience, followed by a short questionnaire about your background.
Participants will receive $50 for completing the study and reimbursement for travel costs.
Mass General and Brigham and Women’s Hospital
617-724-5946
allergyresearch@mgh.harvard.edu
Tufts Medicine
617-636-4226
peneq@tuftsmedicine.org
